Summary
CVS Health Corporation (CVS) filed an 8-K on November 6, 2017, primarily to announce its earnings for the third quarter ended September 30, 2017. The report itself is brief, mainly referencing an attached press release (Exhibit 99.1) that contains the detailed financial results and operational highlights. Investors should refer to this press release for specific performance metrics, revenue figures, earnings per share, and any forward-looking guidance provided by the company. The filing confirms that the information furnished is not being filed for incorporation into future registration statements unless explicitly stated, a standard disclosure for earnings releases.
Key Highlights
- 1CVS Health announced its third-quarter 2017 earnings on November 6, 2017.
- 2The 8-K filing serves as a notification of the earnings release.
- 3Detailed financial results and operational data are contained within the attached press release (Exhibit 99.1).
- 4The information provided is furnished, not filed, meaning it has less regulatory impact on future SEC filings.
- 5Investors should consult the press release for specific performance metrics and guidance.
- 6The reporting period covered is the three months ended September 30, 2017.
Frequently Asked Questions
The main purpose of this 8-K filing is to officially announce and provide access to CVS Health's earnings results for the third quarter of 2017. It directs investors to a press release containing the detailed financial information.
The actual financial results, including revenue, earnings per share, and any commentary on performance, are located in the press release dated November 6, 2017, which is attached as Exhibit 99.1 to this 8-K filing.
No, the information in this 8-K filing, specifically the earnings release, is being 'furnished,' not 'filed.' This means it generally won't be automatically incorporated into future SEC registration statements unless CVS Health explicitly states otherwise.
This report covers the financial results for the three months ended September 30, 2017, which corresponds to the third quarter of CVS Health's fiscal year.